Since mechanisms of host immune evasion by the tumor, along with genomic and mutational complexity, are expectantly more pronounced in advanced-stage tumors, future studies are warranted to fully probe CD73, and other members of the adenosine pathway, along the continuum of different stages (e.g., early, local/oligometastatic to distant metastatic) in LUAD. Here, NT5E is linked to neoplasm.